Robert Schmidt

Founder, CEO and Chairman of the Board of Directors, Great Lakes NeuroTechnologies Inc., 2010-present. GLNeuroTech develops and manufactures movement disorder medical devices and electrophysiology devices for education and research. Kinesia One™ and Kinesia 360™ provide physicians a way to quantify and better treat movement disorders such as Parkinson’s disease. Kinesia ProView™ provides Deep Brain Stimulation surgeons and DBS clinicians a way to evaluate the tuning of DBS devices. The BioRadio® and BioRadio Lab Course are tools for universities and high schools to use for research and teaching. The BioRadio is being used in several cardio/pulmonary drug studies to monitor patients at home. Products have been sold on all seven continents.

• Founder, CEO and Chairman of the Board of Directors, NeuroWave Systems Inc., 2005-present. NeuroWave is a developing and manufacturing a number of EEG-based cortical devices. The NeuroSENSE® is used for depth of anesthesia monitoring. NeuroMedic® and NeuroFAST™ are used to detect non-convulsive seizures. NeuroGuard™ detects brain dysfunction and NeuroAD™ provides a quantitative measurement for diagnosis of ADHD. Auto-TIVA™ is being developed to automatically administer both the anesthetic and analgesic using the patient’s EEG as the input. Seiz-TBI™ will provide indication of traumatic brain injury of patients at the point of injury.

Board Member of the Small Business Technology Council (SBTC.org), a council of the National Small Business Association (NSBA.biz) from 2007 to present. Co-Chair from February, 2013-Present. SBTC advocates for the 6,000 Small Business Innovation Research (SBIR) companies who participate in this $3.5 B federal program to create new innovative companies. Advocate for stronger patents (see sbtc.org/patents). Schmidt was named "SBIR Person of the Year for 2015" (http://www.zyn.com/sbir/articles/15poy.htm).

• Chairman of the Board of Directors, Flocel Inc., 2005-present. Flocel has developed and sells around the world an in-vitro test for the permeability of the Blood Brain Barrier (BBB). It is used for drug discovery to test new drugs on the BBB, and for personalized medicine to determine which drugs are most effective in permeating the BBB for cortical medicine delivery.

Founder and Chairman, Cleveland Medical Devices Inc., 12/90-Present. CleveMed develops, manufactures, and markets sleep disorders products. The leading products are the SleepView® and the SleepView Web Portal. SleepView Direct has experienced 15% growth this year. - Principal Investigator, “A New Device for Untethered Home Sleep Studies ," Phase II SBIR, NINDS, 9/02-2005. Developed a home monitor for sleep disordered breathing and to diagnose other sleep disorders. The device allows for remote real-time monitoring. Obtained FDA 510(k) approval for the Crystal Monitor – Model 20 Family of Monitors . - Principal Investigator, “Emergency Brain Monitor with Telemetry," Phase II SBIR, NINDS, 9/02-2004. Developed a simple to use device to monitor people in ambulances and emergency departments for non-convulsive seizures. Obtained FDA 510(k) approval for the Crystal Monitor – Model 16. - -Principal Investigator, “A New Device for Untethered Home Sleep Studies," Phase I SBIR, NINDS, 9/99-9/00. Developed a prototype device to monitor individuals at home for sleep disorders. - Program Manager, “Wireless EEG Monitor System," SBIR contract, NINDS, 7/97-9/00. Developed an 8-channel wireless EEG machine for detecting non-convulsive seizures. Obtained FDA 510(k) approval for the Crystal EEG – Model 15. Principal Investigator, “Ambulatory Wireless Sleep Monitor," Phase I & II SBIR, NHLBI, 9/96-3/01. Developed a wireless sleep monitor that allowed polysomnograms to be collected from untethered patients. - Principal Investigator (Ph I)/ Management Sponsor (Ph II),“Portable Wireless Epilepsy EEG Monitor," Phase I SBIR, NINDS, 6/96-8/99. Developed an 8-channel wireless EEG machine. Obtained FDA 510(k) approval for the Crystal EEG- Model 10. - Principal Investigator (Ph I)/ Management Sponsor (Ph II), " Miniature Narrow Band Telemetry System for EEG and AER," NIMH, 11/95-8/99. Developed the world’s first digital wireless EEG machine.

• Founder, CEO, and Chairman, Orbital Research Inc., 12/90-present. - Program Manager, "Development of a Refreshable Braille Display System," NEI, 3/96-4/97. This program is developing a computer monitor for the blind using a novel micro-valve to provide pneumatic actuation to Braille characters to allow instant refreshing of a Braille display. - Principal Investigator, "A Novel Microactuator for the Refreshable Braille Display System," Department of Education, designed a new micron size sliding microvalve using silicon technology, 9/94-3/95. - Principal Investigator (Ph I)/ Management Sponsor (PhII), "Large Throw, Imbedded Microactuator Drag Reducers," USAF/, 9/94-7/98. This program provided the first wind tunnel tests showing the efficacy of “Aerionic” devices. - Principal Investigator, "Microactuator Arrays for Adaptable Control Surfaces," DARPA, 1992. This program was this first of many to develop a new field of fluid dynamics called “Aerionics,” or third generation flight control. The technology uses micro-devices for macro control of flight vehicles such as aircraft, UAVs, and slender bodies. - Program Manager, "A More Efficient Controller, Phase I & II SBIR, NASA-Langley. Developing a novel multi-input, multi-output adaptive predictive controller for control of aircraft and machinery. The advanced software is run on our proprietary controller hardware. 3/92-4/95. - Consultant to the Center for Materials for Space Structures, a NASA Center for the Commercial Development of Space, Case Western Reserve University, 12/90-4/92. Responsible for materials space flight experiments. Coordinated efforts from materials suppliers to acquire advanced materials to fly on the Space Shuttle and on the Wakeshield to evaluate the effects of atomic oxygen and the low earth environment on candidate space materials, particularly on lighter weight polymers and “self-healing” materials.